1. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

2. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

3. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

4. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

5. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

6. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

7. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

8. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

9. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

10. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293

11. Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): 293-300; DOI: 10.3238/arztebl.2014.0293